🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety and tolerability at increasing dose levels of PF-06863...
Status
Completed
Location
UCSD Medical Center - Encinitas
Start Date
2017-11-29
Trial ID
NCT03269136
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-express...
Status
Recruiting
Location
Jupiter Medical Center/Anderson Family Cancer Institute
Start Date
2022-11-10
Trial ID
NCT05623020
Treatments Being Tested
To learn if giving elranatamab before and after an autologous stem cell tra...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-07-17
Trial ID
NCT06207799
Treatments Being Tested
This research study is being done to compare the efficacy and safety of the...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-08-01
Trial ID
NCT07247097
The purpose of this study is to evaluate whether elranatamab monotherapy ca...
Status
Active Not Recruiting
Location
Banner Gateway Medical Center
Start Date
2022-03-25
Trial ID
NCT05317416
Treatments Being Tested
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bis...
Status
Recruiting
Location
Clovis Community Medical Center
Start Date
2021-10-04
Trial ID
NCT05020236
Treatments Being Tested
The purpose of this study is to determine the Recommended Phase 2 Dose and ...
Status
Terminated
Location
Banner Gateway Medical Center
Start Date
2021-10-27
Trial ID
NCT05090566
Treatments Being Tested
The purpose of this study is to learn about the study medicine called elran...
Status
Recruiting
Location
Infirmary Cancer Care
Start Date
2024-02-08
Trial ID
NCT06152575
Treatments Being Tested